Clinical Trial Supply Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Clinical Trial Supply Market is segmented by Clinical Phase (Phase 1, Phase 2, Phase 3, and others), Services (Manufacturing, Storage and Distribution, and Supply Chain Management), Application (Oncology, Central Nervous System, Infectious Diseases, Metabolic Disorder, Cardiovascular and Others), End-User (Pharmaceuticals, Biologics, Medical Devices, and Others), Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD million) for the above segments.

Clinical Trial Supply Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Clinical Trial Supply Industry Overview

The Clinical Trial Supply market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares key players in the clinical trial supplies market include Thermo Fisher Scientific (US), Catalent, Inc. (the US), Parexel (US), Almac Group (UK), Marken (US), Piramal Pharma Solutions (India), UDG Healthcare (Ireland).

Clinical Trial Supply Market Leaders

  1. Thermo Fisher Scientific

  2. Catalent

  3. Paraxel

  4. Almac Group

  5. Marken

  6. *Disclaimer: Major Players sorted in no particular order
Thermo Fisher Scientific (US), Catalent, Inc. (the US), Parexel (US), Almac Group (UK), Marken (US), Piramal Pharma Solutions (India), UDG Healthcare (Ireland).

Global Clinical Trial Supply Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?